Article Information
History
- July 16, 2021.
Article Versions
- Version 1 (May 21, 2021 - 10:06).
- Version 2 (May 30, 2021 - 23:30).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brittany Rife Magalis1,2,
- Carla Mavian1,2,
- Massimiliano Tagliamonte1,2,
- Shannan N. Rich1,3,4,
- Melanie Cash1,2,
- Alberto Riva5,
- Julia C. Loeb1,6,
- Michael Norris1,6,
- David Moraga Amador5,
- Yanping Zhang5,
- Jerne Shapiro3,4,
- Petr Starostik2,
- Simone Marini1,3,
- Paul Myers4,
- David Ostrov2,
- John A. Lednicky1,6,
- J. John Glenn Morris Jr.1,
- Michael Lauzardo1,4,7 and
- Marco Salemi1,2,$
- 1Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA, 32610
- 2Department of Pathology, University of Florida, Gainesville, FL, USA, 32610
- 3Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA, 32610
- 4Florida Department of Health, Alachua County, Gainesville, FL, USA, 32641
- 5Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL, USA, 32610
- 6Department of Environmental and Global Health, University of Florida, Gainesville, Florida 32610
- 7Division of Infectious Diseases and Global Medicine, College of Medicine, University of Florida, Gainesville, FL, USA, 32610
- ↵$Corresponding author; email: salemi{at}pathology.ufl.edu
Posted July 16, 2021.
SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments
